Sfoglia per Autore
Six months of resveratrol supplementation has no measurable effect in type 2 diabetic patients. A randomized, double blind, placebo-controlled trial
2016-01-01 Bo, S; Ponzo, V.; Ciccone, G.; Evangelista, A.; Saba, F.; Goitre, I.; Procopio, M.; Pagano, G.F.; Cassader, M.; Gambino, R.
A novel approach to control hyperglycemia in type 2 diabetes: Sodium glucose co-transport (SGLT) inhibitors. Systematic review and meta-analysis of randomized trials.
2012-01-01 Musso G; Gambino R; Cassader M; Pagano G
Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity.
2011-01-01 Musso G; Gambino R; Cassader M; Pagano G.
Loxin polymorphism is associated with increased resistin levels and with oxidative status.
2011-01-01 Gambino R; Bo S; Musso G; Pagano G; Cassader M
La determinazione del polimorfismo di TCF7L2 può essere utile nella predizione dell'alterato metabolismo glucidico?
2010-01-01 Gambino R; Bo S; Alemanno N; Gentile L; Cassader M; Pagano G.
Transcription factor 7-like 2 (TCF7L2) polymorphism and hyperglycemia in an adult Italian population-based cohort.
2010-01-01 Gambino R; Bo S; Gentile L; Musso G; Pagano G; Cavallo-Perin P; Cassader M.
LOXIN POLYMORPHISM IS ASSOCIATED WITH INCREASED RESISTIN LEVELS AND WITH OXIDATIVE STATUS.
2010-01-01 R. Gambino; S. Bo; N. Alemanno; G. Pagano; P. Cavallo-Perin; M. Cassader.
Il polimorfismo-866 G/A di UCP2 è associato con i livelli plasmatici di proteina C reattiva in soggetti con diabete tipo 2.
2010-01-01 Lapice E; Pinelli M; Pisu E; Monticelli A; Gambino R; Pagano G; Cocozza S; Riccardi G; Vaccaro O.
Evaluation of TCF7L2 polymorphism as a new tool in the prediction of impaired fasting glucose and diabetes.
2010-01-01 R.Gambino; S. Bo; G. Pagano; N.Alemanno; M. Cassader
IS THE DETERMINATION OF TCF7L2 POLYMORPHISM A USEFUL MARKER IN THE PREDICTION OF IMPAIRED GLUCOSE METABOLISM?
2010-01-01 R.Gambino; S. Bo; N.Alemanno; M. Cassader; P. Cavallo-Perin; G.Pagano.
A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease.
2010-01-01 Musso G; Gambino R; Cassader M; Pagano G.
Uncoupling protein 2 G(-866)A polymorphism: a new gene polymorphism associated with C-reactive protein in type 2 diabetic patients
2010-01-01 Lapice E; Pinelli M; Pisu E; Monticelli A; Gambino R; Pagano G; Valsecchi S; Cocozza S; Riccardi G; Vaccaro O.
Potential prognostic value of TCL7L2 polymorphism in the prediction of impaired fasting glucose and diabetes.
2009-01-01 R.Gambino; S. Bo; G. Pagano; N.Alemanno; L. Gentile; M. Cassader.
Transcription factor 7-like 2 polymorphism modulates glucose and lipid homeostasis, adipokine profile, and hepatocyte apoptosis in NASH
2009-01-01 Musso G; Gambino R; Pacini G; Pagano G; Durazzo M; Cassader M.
What predicts the occurrence of the metabolic syndrome in a population-based cohort of adult healthy subjects?
2009-01-01 Bo S; Rosato R; Ciccone G; Gambino R; Durazzo M; Gentile L; Cassader M; Cavallo Perin P; Pagano G.
High-normal blood pressure is associated with a cluster of cardiovascular and metabolic risk factors: a population-based study
2009-01-01 Simona Bo; Roberto Gambino; Luigi Gentile; Gianfranco Pagano; Rosalba Rosato; Giorgio Maria Saracco; Maurizio Cassader; Marilena Durazzo; Paolo Cavallo-Perin
Type 1 autoimmune hepatitis and adipokines: new markers for activity and disease progression?
2009-01-01 Durazzo M; Niro G; Premoli A; Morello E; Rosa Rizzotto E; Gambino R; Bo S; Musso G; Cassader M; Pagano G; Floreani A.
Effects of TCF7L2 polymorphisms on glucose values after a lifestyle intervention
2009-01-01 Bo S; Gambino R; Ciccone G; Rosato R; Milanesio N; Villois P; Pagano G; Cassader M; Gentile L; Durazzo M; Cavallo-Perin P.
Phytosterol-Enriched Yogurt Increases LDL Affinity and Reduces CD36 Expression in Polygenic Hypercholesterolemia
2009-01-01 Ruiu G; Pinach S; Veglia F; Gambino R; Marena S; Uberti B; Alemanno N; Burt D; Pagano G; Cassader M.
Plasma visfatin concentrations after a lifestyle intervention were directly associated with inflammatory markers
2009-01-01 Bo S; Ciccone G; Baldi I; Gambino R; Mandrile C; Durazzo M; Gentile L; Cassader M; Cavallo-Perin P; Pagano G.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile